Showing results (201-210 of 513) with videos related to
Sort By:
Pageof 52
International Journal of Pediatric Otorhinolaryngology|September 29, 2001
Laryngo-pharyngeal carcinoma in childhoodC Barnes, M Sexton, A Sizeland, et al.BMJ (Clinical Research Ed.)|November 20, 1998
Sex differences in the use of asthma drugs: cross sectional studyM Sexton, M D Althuis, N Santanello, et al.Molecular Pharmacology|March 15, 2006
Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptorsMadhara Udawela, George Christopoulos, Nanda Tilakaratne, et al.International Journal of Food Microbiology|June 4, 2013
Effects of egg shell quality and washing on Salmonella Infantis penetrationSamiullah, K K Chousalkar, J R Roberts, et al.Journal of Applied Microbiology|June 8, 2012
Antimicrobial susceptibilities and resistance genes in Campylobacter strains isolated from poultry and pigs in AustraliaA S Obeng, H Rickard, M Sexton, et al.Neuroscience|September 1, 1994
In vitro autoradiographic localization of amylin binding sites in rat brainP M Sexton, G Paxinos, M A Kenney, et al.ACS Chemical Neuroscience|September 5, 2014
Development of a photoactivatable allosteric ligand for the m1 muscarinic acetylcholine receptorBriana J Davie, Patrick M Sexton, Ben Capuano, et al.Progress in Molecular Biology and Translational Science|August 10, 2010
Receptor activity modifying proteins and their potential as drug targetsDenise L Wootten, John Simms, Debbie L Hay, et al.Molecular Pharmacology|February 9, 2011
The role of transmembrane domain 3 in the actions of orthosteric, allosteric, and atypical agonists of the M4 muscarinic acetylcholine receptorKatie Leach, Anna E Davey, Christian C Felder, et al.Drug Discovery Today|January 20, 2009
Modulating receptor function through RAMPs: can they represent drug targets in themselves?Patrick M Sexton, David R Poyner, John Simms, et al.Pageof 52